Raising the standards of trial-based economic evaluation: the devil is in the detail.
Backhouse
Martin E
ME
D026683:Advisory Committees; D003362:Cost-Benefit Analysis / Q000592:standards*; D004341:Drug Evaluation / Q000191:economics*; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D006801:Humans; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D006113:United Kingdom; D014481:United States